Glaxosmithkline | GSK - Market Capitalization

Stock Price
49.66
Daily Change
-1.24 -2.44%
Monthly
-1.66%
Yearly
31.93%
Q2 Forecast
48.78

Glaxosmithkline reported GBP102.83B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pfizer USD 147.4B 6.42B May/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.57B 233M May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Supernus Pharmaceuticals USD 2.82B 155M May/2026
Takeda JPY 8.33T 681.01B May/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Zoetis USD 39.98B 9.73B May/2026